Clinical Trial

Efficacy and Safety of VMX Eye Drops for Dry Eye Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This multicenter, randomized, double-blind study evaluates the safety and effectiveness of VMX eye drops in patients with dry eye disease. It aims to improve tear film stability, reduce dry eye symptoms, and enhance patients' quality of life compared to standard treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-17.
Trial Details
NCT Number NCT07369375
Lead Sponsor VISUfarma SpA
Collaborators: CROlife
Conditions Dry Eye Disease (DED)
Enrollment 76 participants
Start Date 2026-02-02
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-29